Biomarkers in Urologic Cancer, An Issue of Urologic Clinics of North America

Description

The past decade has been marked by the acceleration of our understanding of the molecular biology of cancer. Simultaneously, there have been increasing exigencies to diagnose, treat and follow cancer patients more economically. Biomarkers represent the marriage of science and economics. Biomarkers offer the potential to increase the precision of diagnosis, prognosis, and surveillance of urological malignancies. This issue presents the cutting-edge advances of biomarker technology to urologic oncology.

Companion Products

• Biomarkers in Urologic Cancer, An Issue of Urologic Clinics of North America

Author Information

By Kevin R. Loughlin, MD, MBA, Emeritus Professor of Surgery (Urology), Harvard Medical School, Visiting Scientist, Vascular Biology Research Program at Boston Children’s Hospita